Variables | |
Demographics | |
Age | 54±15 (18–77) |
Sex | 39 (71%) |
Familial history | |
Family history of sudden death | 10 (18%) |
Family history of HCM | 7 (12%) |
Medical history | |
Hypertension | 30 (54%) |
Diabetes | 6 (11%) |
Obesity | 16 (29%) |
Dyslipidemia | 25 (45%) |
Stroke | 11 (20%) |
Chronic renal failure* | 8 (14%) |
Pacemaker | |
Symptoms | |
NYHA I | 38 (69%) |
II | 13 (23%) |
III | 4 (7%) |
IV | 0 |
Syncope | 6 (11%) |
Angor | 8 (14%) |
Atrial arrhythmia | 12 (22%) |
Ventricular arrhythmia | 7 (13%) |
No symptoms | 16 (29%) |
ECG | |
Sinusal rhythm | 37 (84%) |
Short PR interval† | 1 (1.5%) |
Sokolow (mm) | 27.5±13 |
Echocardiography | |
Maximal wall thickness | 19±5 (14–30) |
LVEF | 67±12 |
LVOTO | 6 (11%) |
Binary endocardium | 1 (1.5%) |
* Defined by a clearance of the creatinine<60 mL/min.
† Defined by an PR interval<120 ms.
HCM, hypertrophic cardiomyopathy; PR, intervalle Pwave- Rwave.